Hospital Paulistano - Amil Clinical Research ( Site 0263)

São Paulo 01321-001

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Squamous Cell, Non-small-cell Lung

Studies at this site

• A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008) — Completed